Biohaven Ltd. (NYSE: BHVN) is pausing new enrollment in its BHV-7000 program after the FDA imposed a partial clinical hold tied to a metabolite observed during rodent testing. More than 1,200 participants have received BHV-7000 across development, and dosing can continue for patients already …
Burning Rock Biotech’s second-quarterRevenuefell 9.3% to RMB134.7 million (US$19.9 million), while net loss rose to RMB18.4 million (US$2.7 million). For investors, the results show stronger in-hospital revenue alongside weaker central-laboratory and pharma services revenue, while the company points toLong-term Growthand new registration certificates.Key HighlightsBurning …
Candel Therapeutics, Inc. (NASDAQ: CADL) appointed Martine Zimmermann to its board with an option to purchase 64,000 common shares. The appointment adds regulatory and quality expertise as Candel advances toward a plannedBiologicsLicense Application submission and potential commercial readiness.
Cellyan Biotechnology Co. Ltd (NASDAQ: HKPD) is seeking shareholder approval for a share consolidation that it believes could help maintain its Nasdaq listing if the Class A ordinary share closing price exceeds $1.00 per share. The company also cautions that the action may not …
The notice places the activity in the Other Health Care category and identifies Kevin Francis Kast as an executive officer. The offering notice carries the date 28 August 2026.
Braskem S.A. (NYSE: BAK) reports an opening balance of 42.150 treasury shares in its Class A preferred share category. The balance is presented in the company’s monthly securities information under Article 11 of CVM Instruction #44/2021. The record identifies the treasury-share position and its …
BRASKEM SA (NYSE: BAK) amended its natural gas supply agreement with Petrobras, setting an estimated post-amendment contract value of BRL 1,850,000,000. The arrangement covers preferential supply for Braskem facilities in Brazil or adjustments to its portfolio.
Brown & Brown, Inc. (NYSE: BRO) has set out its 2026 Company Overview, covering operating measures and cautions tied to future results.
Canada Goose Holdings Inc. (NYSE: GOOS) CEO Dani Reiss acquired 100,000 subordinate voting shares on September 9, 2026, through DTR LLC in open-market purchases. The transaction carried an average price of $10.623 per share and an aggregate cost of approximately $1,062,300.
Cardlytics, Inc. (NASDAQ: CDLX) agreed to resolve Amit Jain’s indemnification claim for an aggregate $6.4 million, covering his portion of the DailyGobble settlement and related legal fees. The settlement agreement calls for an aggregate wire payment of $6,441,649.40 and transfers Jain’s rights in the …